Michael Dickinson
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Oncology top 2%
- CAR-T cell therapy research
Papers in
- Oncology 110
- CAR-T cell therapy research 86
-
- Lymphoma Diagnosis and Treatment 100
- Co-authors
- H. Miles Prince (32 shared papers)Ricky W. Johnstone (3 shared papers)Malik Khalfan (5 shared papers)Amit Khot (11 shared papers)David Ritchie (12 shared papers)John F. Seymour (27 shared papers)Simon J. Harrison (16 shared papers)Adrian Minson (19 shared papers)
- Journals
- Blood (49 papers)Hematological Oncology (13 papers)Journal of Clinical Oncology (13 papers)British Journal of Haematology (12 papers)HemaSphere (8 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Michael Dickinson
181 papers receiving 2.9k citations
Michael Dickinson's Hit Papers
Peers
Comparison fields: 5 of 116
- Pathology and Forensic Medicine 1.1k
- Oncology 1.4k
- Genetics 358
- Dermatology 267
- Hematology 320
Countries citing papers authored by Michael Dickinson
This map shows the geographic impact of Michael Dickinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dickinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dickinson more than expected).
Fields of papers citing papers by Michael Dickinson
This network shows the impact of papers produced by Michael Dickinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dickinson. The network helps show where Michael Dickinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Dickinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial Hit paper breakdown → | 2022 | 200 |
| 2 | 2014 | 159 | |
| 3 | 2010 | 123 | |
| 4 | 2014 | 94 | |
| 5 | 2012 | 84 | |
| 6 | 2009 | 71 | |
| 7 | 2007 | 70 | |
| 8 | 2018 | 69 | |
| 9 | 2011 | 62 | |
| 10 | 2009 | 62 | |
| 11 | 2006 | 61 | |
| 12 | 2014 | 60 | |
| 13 | 2010 | 57 | |
| 14 | 2021 | 52 | |
| 15 | 2023 | 52 | |
| 16 | 2013 | 51 | |
| 17 | 2017 | 46 | |
| 18 | 2020 | 46 | |
| 19 | 2017 | 43 | |
| 20 | 2008 | 40 |
About Michael Dickinson
Michael Dickinson is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Molecular Biology, having authored 191 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (100 papers), CAR-T cell therapy research (86 papers), Chronic Lymphocytic Leukemia Research (28 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), CNS Lymphoma Diagnosis and Treatment (15 papers), Biosimilars and Bioanalytical Methods (14 papers), Cutaneous lymphoproliferative disorders research (14 papers) and Histone Deacetylase Inhibitors Research (12 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Oncology (1.4k citations), Genetics (358 citations), Dermatology (267 citations) and Hematology (320 citations). Michael Dickinson has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include H. Miles Prince, Ricky W. Johnstone, Malik Khalfan, Amit Khot, David Ritchie, John F. Seymour, Simon J. Harrison, Adrian Minson, David Westerman and Franck Morschhauser. Their work appears in journals such as Blood, Hematological Oncology, Journal of Clinical Oncology, British Journal of Haematology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.